bridges-research.eu | Bridges Research | Breast Cancer Risk after Diagnostic Gene

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap:

Meta Tags

Title	Bridges Research \| Breast Cancer Risk after Diagnostic Gene
Description	About Project BRIDGES Participants Meetings Library FAQs BRIDGES publications Literature Deliverable reports Milestones Other dissemination Collaborations
Keywords	N/A

Server Information

WebSite	bridges-research.eu
Host IP	136.144.212.73
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

bridges-research.eu Valuation

US$507,900

Last updated: 2023-05-15 18:05:18

bridges-research.eu has Semrush global rank of 20,839,353. bridges-research.eu has an estimated worth of US$ 507,900, based on its estimated Ads revenue. bridges-research.eu receives approximately 58,604 unique visitors each day. Its web server is located in United States, with IP address 136.144.212.73. According to SiteAdvisor, bridges-research.eu is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$507,900
Daily Ads Revenue	US$469
Monthly Ads Revenue	US$14,065
Yearly Ads Revenue	US$168,780
Daily Unique Visitors	3,907
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
bridges-research.eu.	A	60	IP: 136.144.212.73
bridges-research.eu.	NS	86400	NS Record: ns11.net.
bridges-research.eu.	NS	86400	NS Record: ns0.nl.
bridges-research.eu.	NS	86400	NS Record: ns5.be.
bridges-research.eu.	MX	60	MX Record: 10 mail02.compleet.it.

HtmlToTextCheckTime:2023-05-15 18:05:18

About Project BRIDGES Participants Meetings Library FAQs BRIDGES publications Literature Deliverable reports Milestones Other dissemination Collaborations Contact Partner login Official documents Reporting and planning Acknowledgement Logo Select Page Breast Cancer Risk after Diagnostic Gene Sequencing Breast cancer affects more than 360,000 women per year in the EU and causes more than 90,000 deaths. Identification of women at high risk of the disease can lead to disease prevention through intensive screening, chemoprevention or prophylactic surgery. Breast cancer risk is determined by a combination of genetic and lifestyle risk factors. The advent of next generation sequencing has opened up the opportunity for testing in many disease genes, and diagnostic gene panel testing is being introduced in many EU countries. However, the cancer risks associated with most variants in most genes are unknown. This leads to a major problem in appropriate counselling and management of women

HTTP Headers

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Fri, 07 Jan 2022 09:00:12 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: https://bridges-research.eu/

HTTP/2 200 
server: nginx
date: Fri, 07 Jan 2022 09:00:14 GMT
content-type: text/html; charset=UTF-8
x-powered-by: PHP/7.4.27
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
x-powered-by: PleskLin

bridges-research.eu Whois Information

Domain: bridges-research.eu
Script: LATIN
NOT DISCLOSED!
Visit www.eurid.eu for webbased WHOIS.
NOT DISCLOSED!
Visit www.eurid.eu for webbased WHOIS.
Name: TransIP Group BV
Website: http://transip.nl
ns0.nl
ns11.net
ns5.be
flags:KSK protocol:3 algorithm:ECDSA_P256_SHA256 pubKey:YVoDBlffpNIT/V2iMxmXQ8zE+rZkLL6eirkXDKOVAKlOUlKds4tWgmwIR7/BKmsU8uiVDZgzSMx7y7DYLX+vjQ==
Please visit www.eurid.eu for more info.

bridges-research.eu valuation and analysis